Skip Navigation

U.S. Should Stop Funding the International Agency for Research on Cancer

September 19, 2018

The United States should stop funding the International Agency for Research on Cancer which uses outdated, faulty methodologies and produces outcomes often driven by political considerations.

The International Agency for Research on Cancer (IARC) uses outdated and faulty methodologies and its outcomes are often driven by political considerations, leading to inappropriate cancer classifications. IARC’s faulty conclusions can create serious problems, including bans on useful products, consumers choosing not purchase or even to boycott perfectly safe, effective, often superior products, and unwarranted fear of cancer risks. IARC is partly funded by U.S. government grants, and because the agency has been unwilling to change the way it operates to improve its research protocols and procedures and use the best, publicly available, science and remove political influence, the U.S. should stop funding the agency.

Author
Angela Logomasini is a Senior Fellow at the Competitive Enterprise Institute, focusing on environmental regulation, particularly chemical regulation.
Angela.Logomasini@cei.org